What is HealthCare Global Enterprises Days Payable?
HealthCare Global EnterprisesNSE:HCG +2.37%79 Days Payable is 101.04 as of Mar. 2026, which is 6% below its 10-year median of 107.70. GuruFocus rates NSE:HCG with a GF Score™ of 79/100 and a GF Value™ of ₹577.64 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks better than 70.84% on this metric.
The historical rank and industry rank for HealthCare Global Enterprises's Days Payable or its related term are showing as below:
NSE:HCG'
s Days Payable Range Over the Past 10 Years
Min: 90.83 Med: 107.7 Max: 129.3
Current: 104.7
During the past 12 years, HealthCare Global Enterprises's highest Days Payable was 129.30. The lowest was 90.83. And the median was 107.70.
NSE:HCG's Days Payable is ranked better than 70.84% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs NSE:HCG: 104.70
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Days Payable distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's Days Payable falls into.
HealthCare Global Enterprises Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises (NSE:HCG) has a Days Payable of 101.04 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HealthCare Global Enterprises and its competitors. This is near median its historical median of 107.70. Over the past decade, HealthCare Global Enterprises' Days Payable has ranged from 90.83 to 129.30. According to the industry distribution chart, HealthCare Global Enterprises ranks #177 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 29.2%.
Is HealthCare Global Enterprises' Days Payable too high?
HealthCare Global Enterprises' current Days Payable of 101.04 is near median its 10-year median of 107.70. Over the past 10 years, this metric has ranged from a low of 90.83 to a high of 129.30. The Healthcare Providers & Services industry median Days Payable is 58.00. HealthCare Global Enterprises' value of 101.04 is 74.2% above this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #177 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #177 out of 607 companies for Days Payable. This puts HealthCare Global Enterprises in the upper half of its industry. The industry median Days Payable is 58.00. HealthCare Global Enterprises' value of 101.04 is 74.2% above this benchmark. Historically, HealthCare Global Enterprises' own Days Payable has ranged from 90.83 to 129.30 over the past decade. While the company's 10-year median is 107.70 vs. the industry median of 58.00, HealthCare Global Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Days Payable of 101.04 is 74.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Days Payable is 101.04, which is near median its own 10-year median of 107.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹577.64, compared to a current price of ₹649.00 — trading 12.4% above its estimated fair value. The current Days Payable is 101.04, which is near median its 10-year median of 107.70 and 74.2% above the Healthcare Providers & Services industry median of 58.00. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Days Payable is 101.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹649.00 is trading 12.4% above its estimated GF Value™ of ₹577.64.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
Days Payable: 101.04 (near median its 10-year median of 107.70)
GF Value™: ₹577.64 vs. price of ₹649.00 (12.4% above fair value)
Industry Position: 74.2% above the Healthcare Providers & Services median (#177 of 607)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score
Get the complete analysis for NSE:HCG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
